National Institute for Pharmaceutical Technology and Educa logo

National Institute for Pharmaceutical Technology and Educa

MINNEAPOLIS, MN EIN: 26-0636598 Website

The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chair resilience-ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$3.1M

+128.6% YoY

Annual Giving

$2.9M

+163.1% YoY

Grant Count

10

+11.1% YoY

Avg Grant Size

$289K

+136.8% YoY

About National Institute for Pharmaceutical Technology and Educa

Based on IRS filings

National Institute for Pharmaceutical Technology and Educa is a nonprofit organization focused on Philanthropy, Voluntarism & Grantmaking, based in MINNEAPOLIS, MN. IRS filing data is available from 2021 through 2024. As of 2024, the organization holds $3.1M in total assets. In 2024, it awarded 10 grants totaling $2.9M. Net investment income was $48K.

Ready to take the next step with National Institute for Pharmaceutical Technology and Educa?

Geographic Focus

Where this funder awards grants

Grant Distribution by State

12states
+5 more states

Cities

Ann ArborAustinBaltimoreBostonCambridgeIowa CityKingsvilleMinneapolisPiscatawayPittsburghRichmondRockvilleSan JuanStorrsWest LafayetteWest Lafyaette

Financial History

Multi-year comparison from IRS filings

Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$1M$2M$3M$4M2021202220232024
Metric202420232022
Total Assets$3,127,427$1,368,270$1,067,996
Revenue$3,032,204$1,485,741$998,016
Expenses$3,987,921$1,562,545$1,150,877
Qualifying Distributions
Net Investment Income$48,079$28,761$18,014
Distributable Amount

Giving Over Time

Total grant dollars and number of grants per year

$0$723K$1M$2M$3M7 grants20219 grants20229 grants202310 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

Rutgers University$1.2MVirginia Commonwealth Un…$581KUniversity of Minnesota$371KMassachusetts Institute …$298KUniversity of Iowa$240KNortheastern University$86KPurdue University$77KDuquesne University$33KUniversity of Connecticut$18KUniversity of Puerto Rico$17K

Grant Size Distribution

35 grants across all recorded years

11<$50K7$50–100K11$100–250K4$250–500K1$500K–1M1$1–5M$5M+

Open Grants

4 open opportunities from National Institute for Pharmaceutical Technology and Educa

Show all 4 →

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Officers and directors from IRS filings

Compensation Overview

From 2024 IRS filing

From 2024 filing

NameTitleHoursCompensation
Arash T DebastaniBoard Member1
Sarah MichelBoard Member1
Vicki EllingrodBoard Member1
Donna StrumTreasurer1
Alberto CuitinoBoard Member1
Kelechi C OgbonnaSecretary1
Eric L BarkerBoard Member1
Barbara TimmermannBoard Member1
Philip HritckoVice Chair1
James K DrennenChair1
Vadim J GurvichExective Director20
Amy PittingerBoard Member1
Kevin CasselBoard Member1
Wanda MaldonadoBoard Member1
Martin S ZandBoard Member1
Paul BryceBoard Member1

Subject Areas

Focus areas based on grantmaking activity

Related Funders

Similar funders by location and focus area

Data last updated April 2026. Sourced from IRS Form 990-PF filings.

What could you do with National Institute for Pharmaceutical Technology and Educa on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities